Amrize Ltd (AMRZ)vsCementos Pacasmayo SAA ADR (CPAC)
AMRZ
Amrize Ltd
$40.52
+0.20%
BASIC MATERIALS · Cap: $23.97B
CPAC
Cementos Pacasmayo SAA ADR
$12.54
-0.32%
BASIC MATERIALS · Cap: $1.07B
Smart Verdict
WallStSmart Research — data-driven comparison
Amrize Ltd generates 442% more annual revenue ($12.18B vs $2.25B). AMRZ leads profitability with a 10.1% profit margin vs 9.5%. CPAC appears more attractively valued with a PEG of 1.13. CPAC earns a higher WallStSmart Score of 68/100 (B-).
AMRZ
Strong Buy68
out of 100
Grade: B-
CPAC
Strong Buy68
out of 100
Grade: B-
Intrinsic Value Comparison
Multi-model valuation · Graham Formula
Intrinsic value data unavailable for AMRZ.
Margin of Safety
+15.9%
Fair Value
$12.95
Current Price
$12.54
$0.41 discount
Key Strengths & Concerns
Side-by-side fundamental analysis
Key Strengths
Reasonable price relative to book value
Strong operational efficiency at 20.5%
Earnings expanding 61.5% YoY
Attractively priced relative to earnings
Reasonable price relative to book value
Strong operational efficiency at 24.4%
15.4% revenue growth
Areas to Watch
Distress zone — elevated risk
Weak financial health signals
Distress zone — elevated risk
Smaller company, higher risk/reward
Elevated debt levels
Comparative Analysis Report
WallStSmart ResearchBull Case : AMRZ
The strongest argument for AMRZ centers on Price/Book, Operating Margin. PEG of 1.13 suggests the stock is reasonably priced for its growth.
Bull Case : CPAC
The strongest argument for CPAC centers on EPS Growth, P/E Ratio, Price/Book. Revenue growth of 15.4% demonstrates continued momentum. PEG of 1.13 suggests the stock is reasonably priced for its growth.
Bear Case : AMRZ
The primary concerns for AMRZ are Altman Z-Score, Piotroski F-Score.
Bear Case : CPAC
The primary concerns for CPAC are Altman Z-Score, Market Cap, Debt/Equity.
Key Dynamics to Monitor
AMRZ profiles as a value stock while CPAC is a growth play — different risk/reward profiles.
CPAC is growing revenue faster at 15.4% — sustainability is the question.
CPAC generates stronger free cash flow (176M), providing more financial flexibility.
Monitor BUILDING MATERIALS industry trends, competitive dynamics, and regulatory changes.
Bottom Line
AMRZ scores higher overall (68/100 vs 68/100). CPAC offers better value entry with a 15.9% margin of safety. Both earn "Strong Buy" and "Strong Buy" ratings respectively — the choice depends on your investment horizon and risk tolerance.
This analysis is generated from publicly available financial data. Not financial advice.
Amrize Ltd
BASIC MATERIALS · BUILDING MATERIALS · USA
Amrize Ltd (AMRZ) is an innovative technology firm at the forefront of the digital health and wellness industry, dedicated to transforming healthcare delivery with cutting-edge technologies and data-driven solutions. The company prioritizes enhancing patient outcomes and access to care, significantly investing in research and development to address the rising demand for scalable health innovations. With a diverse portfolio of products and strategic initiatives, Amrize is well-positioned to become a critical player in the ongoing evolution of healthcare, presenting a compelling investment opportunity for institutional investors navigating a dynamic market.
Visit Website →Cementos Pacasmayo SAA ADR
BASIC MATERIALS · BUILDING MATERIALS · USA
Cementos Pacasmayo SAA, a cement company, produces, distributes and sells cement and cement-related materials in Peru. The company is headquartered in Lima, Peru.
Compare with Other BUILDING MATERIALS Stocks
Want to dig deeper into these stocks?